ALIVUS LIFE SCIENCES LTD

ALIVUS

Small Cap | Pharmaceuticals
932.45
+6.79 (+0.73%)

Stock price as on 06 Feb 2026 at 15:30 PM

Alivus life sciences ltd share price update

As of the latest trading session, Alivus Life Sciences Ltd share price is currently at ₹932.45, which is up by ₹6.79 from its previous closing. Today ...

Alivus Life Sciences Ltd stock performance

Today’s low

₹878.4

Today’s high

₹937.95

₹932.45

52 week low

₹819

52 week high

₹1,251

₹932.45
Open
₹930.00
Previous close
₹925.65
Share volume
1,01,797
Total traded value (Lakh)
₹949.20
Upper circuit
₹1,110.75
Lower circuit
₹740.55

Alivus Life Sciences Ltd fundamentals

Market cap (Cr)
₹11,444.60
P/E ratio (TTM)
21.02
Book value per share
₹245.67
Beta
0.91
Return on equity
18.86%
Earnings per share (TTM)
₹45.82
Dividend yield
0.54%
Net profit/quarter (Cr)
₹150.26

Alivus Life Sciences Ltd financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹672.89

Operating expense

₹462.76

Net income

₹150.26

Net profit margin

22.33%

Earning per share

₹12.25

EBITDA

₹219.54

Effective tax rate

24.26%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹587.98

Operating expense

₹428.57

Net income

₹130.03

Net profit margin

22.11%

Earning per share

₹10.60

EBITDA

₹193.89

Effective tax rate

25.33%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹601.85

Operating expense

₹447.85

Net income

₹121.54

Net profit margin

20.19%

Earning per share

₹9.91

EBITDA

₹181.29

Effective tax rate

25.43%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹649.55

Operating expense

₹468.34

Net income

₹141.87

Net profit margin

21.84%

Earning per share

₹11.57

EBITDA

₹208.51

Effective tax rate

25.83%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹641.84

Operating expense

₹467.15

Net income

₹136.96

Net profit margin

21.33%

Earning per share

₹11.18

EBITDA

₹200.77

Effective tax rate

26.02%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹2,386.88

Operating expense

₹1,767.32

Net income

₹485.63

Net profit margin

20.34%

Earning per share

₹39.63

EBITDA

₹717.15

Effective tax rate

25.75%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹2,283.21

Operating expense

₹1,663.97

Net income

₹470.89

Net profit margin

20.62%

Earning per share

₹38.43

EBITDA

₹686.29

Effective tax rate

25.4%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹2,161.22

Operating expense

₹1,561.57

Net income

₹466.96

Net profit margin

21.6%

Earning per share

₹38.11

EBITDA

₹671.25

Effective tax rate

25.71%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹2,123.21

Operating expense

₹1,572.99

Net income

₹418.72

Net profit margin

19.72%

Earning per share

₹35.63

EBITDA

₹630.77

Effective tax rate

25.87%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹1,885.17

Operating expense

₹1,415.04

Net income

₹351.58

Net profit margin

18.64%

Earning per share

₹32.61

EBITDA

₹591.88

Effective tax rate

25.34%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹229.92

Return on Equity (ROE)

18.86%

Return on Capital Employed (ROCE)

24.97%

Total debt to equity ratio

0.01

EBITDA margin

30.05%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹190.35

Return on Equity (ROE)

21.07%

Return on Capital Employed (ROCE)

27.94%

Total debt to equity ratio

0.01

EBITDA margin

30.06%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹174.51

Return on Equity (ROE)

22.28%

Return on Capital Employed (ROCE)

29.86%

Total debt to equity ratio

0.01

EBITDA margin

31.06%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹167.66

Return on Equity (ROE)

29.83%

Return on Capital Employed (ROCE)

42.2%

Total debt to equity ratio

-

EBITDA margin

29.71%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹768.11

Return on Equity (ROE)

60.91%

Return on Capital Employed (ROCE)

96.75%

Total debt to equity ratio

-

EBITDA margin

31.4%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹71.23

Total assets

₹3,411.45

Total liabilities

₹3,411.45

Total equity

₹2,817.37

Shares outstanding

₹12.25

Price to book ratio

₹4.70

Return on assets (%)

14.23%

Return on capital

17.24%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹301.59

Total assets

₹2,850.41

Total liabilities

₹2,850.41

Total equity

₹2,332.32

Shares outstanding

₹12.25

Price to book ratio

₹4.07

Return on assets (%)

16.51%

Return on capital

20.19%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹309.39

Total assets

₹2,702.14

Total liabilities

₹2,702.14

Total equity

₹2,138.20

Shares outstanding

₹12.25

Price to book ratio

₹2.24

Return on assets (%)

17.28%

Return on capital

21.84%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹512.16

Total assets

₹2,471.00

Total liabilities

₹2,471.00

Total equity

₹2,054.31

Shares outstanding

₹12.25

Price to book ratio

₹2.74

Return on assets (%)

16.94%

Return on capital

20.38%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹115.59

Total assets

₹1,997.07

Total liabilities

₹1,997.07

Total equity

₹752.74

Shares outstanding

₹0.98

Price to book ratio

-

Return on assets (%)

17.6%

Return on capital

46.71%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹654.13

Cash from operations

₹554.47

Cash from investing

-₹615.64

Cash from financing

-₹6.23

Net change in cash

-₹230.35

Free cash flow

₹720.66

Particulars

Mar 24 (₹ value in crores)

Net income

₹631.29

Cash from operations

₹576.47

Cash from investing

-₹116.48

Cash from financing

-₹279.44

Net change in cash

₹17.59

Free cash flow

₹705.44

Particulars

Mar 23 (₹ value in crores)

Net income

₹628.60

Cash from operations

₹466.96

Cash from investing

-₹154.14

Cash from financing

-₹387.59

Net change in cash

-₹228.33

Free cash flow

₹637.16

Particulars

Mar 22 (₹ value in crores)

Net income

₹564.92

Cash from operations

₹735.75

Cash from investing

-₹122.22

Cash from financing

-₹78.79

Net change in cash

₹396.56

Free cash flow

₹867.92

Particulars

Mar 21 (₹ value in crores)

Net income

₹470.94

Cash from operations

₹496.67

Cash from investing

-₹68.73

Cash from financing

-₹213.78

Net change in cash

₹105.59

Free cash flow

₹564.67

Alivus Life Sciences Ltd technical summary

₹932.45
+ 0.73 ▲
13
Bearish
3
Bullish
5 Day931.4
10 Day924.9
12 Day922.2
20 Day914.6
26 Day911.4
50 Day908.5
100 Day920.9
200 Day946
5 Day933.3
10 Day930.3
12 Day920.7
20 Day903
26 Day904.2
50 Day899.9
100 Day913.8
200 Day968.4

928.57

PIVOT

First support
₹918.08
First resistance
₹936.13
Second support
₹910.52
Second resistance
₹946.62
Third support
₹900.03
Third resistance
₹954.18
RSI
55.83
ADX
20.92
MACD
10.83
Williams % R
-29.53
Commodity Channel Index (CCI)
34.9
Date
06 Feb 2026
Same day
42,932
Week
27,341
Month
38,928
1 year
0.91
3 years
0.52
Over 1 month
2.82%
Over 1 year
-24.62%
Over 3 months
4.71%
Over 3 years
35.49%
Over 6 months
-1.92%
Over 6 years
4.49%

Investment Returns

Over 1 Month2.82%
Over 3 Months4.71%
Over 6 Months1.92%
Over 1 Year24.62%

Alivus Life Sciences Ltd Shareholding pattern


Public
12.88%
Promoter holdings
74.9%
FII
5.08%
DII
7.12%
Promoter shares
0%
Promoter sharesShareCategory

Nirma Limited

9,18,96,285 (74.91%)

Shareholding of Promoter and Promoter Group

Quant Mutual Fund - Quant Healthcare Fund

30,80,136 (2.51%)

Public Shareholding

Government Pension Fund Global

25,63,000 (2.09%)

Public Shareholding

Icici Prudential Pharma Healthcare And Diaganostic

15,76,606 (1.29%)

Public Shareholding

Massachusetts Institute Of Technology

15,04,000 (1.23%)

Public Shareholding

Promoter sharesShareCategory
Nirma Limited9,18,96,285 (74.91%)Shareholding of Promoter and Promoter Group
Quant Mutual Fund - Quant Healthcare Fund30,80,136 (2.51%)Public Shareholding
Government Pension Fund Global25,63,000 (2.09%)Public Shareholding
Icici Prudential Pharma Healthcare And Diaganostic15,76,606 (1.29%)Public Shareholding
Massachusetts Institute Of Technology15,04,000 (1.23%)Public Shareholding

About ALIVUS LIFE SCIENCES LTD

Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed

Parent Organisation

Indian Private

NSE Symbol

ALIVUS

Founded

2011

ALIVUS LIFE SCIENCES LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
01 Sept 20255Final01 Sept 2025Equity shares
17 Oct 202322.5Interim17 Oct 2023Equity shares
24 Mar 202321Interim24 Mar 2023Equity shares
15 Sept 202210.5Final17 Sept 2022Equity shares
22 Nov 202110.5Interim23 Nov 2021Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)